Hepatitis Monthly

Published by: Kowsar

Adefovir as a Novel Drug for the Treatment of Chronic Hepatitis B in Patients with End-Stage Renal Disease and Kidney Recipients

Seyed Mohammadmehdi Hosseini Moghaddam 1 , * and Elham Iran Pour 2
Authors Information
1 Urology and Nephrology Research Center (UNRC), Shahid Beheshti University, M.C., h_sasan@hotmail.com, IR-Iran
2 Urology and Nephrology Research Center (UNRC), Shahid Beheshti University, M.C., IR-Iran
Article information
  • Hepatitis Monthly: , 8 (2); 135-139
  • Article Type: Review Article
  • Received: December 16, 2007
  • Accepted: May 20, 2008

To Cite: Hosseini Moghaddam S, Pour E. Adefovir as a Novel Drug for the Treatment of Chronic Hepatitis B in Patients with End-Stage Renal Disease and Kidney Recipients, Hepat Mon. Online ahead of Print ;8(2):135-139.

Abstract
© 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments